on 31 Aug 2021
Last Applicant/ Owned by
1334 Main Road
Tiverton
RI
02878
Serial Number
85037493 filed on 13th May 2010
Registration Number
3952824 registered on 26th Apr 2011
Correspondent Address
Francis J. Duffin
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"THERAPY"
"THERAPY" CIRCADIAN NEURO ENDOCRINE RESETTING THERAPY Treatment of obesity, lipid disorders, metabolic disorders, cardiovascular diseases, diseases of the immune system, age-related diseases, cancer, and diseases caused by diabetes such as diabetic neuropathy, obesity, dyslipidemia, hypercholestermia, and hypertension through the therapy of changing the aberrant phase relationships of specific pRead More
Treatment of obesity, lipid disorders, metabolic disorders, cardiovascular diseases, diseases of the immune system, age-related diseases, cancer, and diseases caused by diabetes such as diabetic neuropathy, obesity, dyslipidemia, hypercholestermia, and hypertension through the therapy of changing the aberrant phase relationships of specific pacemaker biological clock circadian peak neuronal outputs, e.g., messaging or transmission, within the central nervous system
16th Jan 2011
16th Jan 2011
No 85037493
No Service Mark
No 204027/US001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 31st Aug 2021 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 31st Aug 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 31st Aug 2021 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 30th Aug 2021 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 24th Aug 2021 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| 11th Aug 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 23rd Apr 2021 | TEAS SECTION 8 & 9 RECEIVED |
| 26th Apr 2020 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 17th May 2016 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 17th May 2016 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
